pancreatic primary tumours; para-tumour normal pancreatic tissues; subcutaneous tumours
Capan-1; SW1990; CFPAC-1; HPDE
cell line-derived xenograft
proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); glycolysis (promotes); ceRNA regulation (other); other pathway/process (promotes)
RNase R Treatment; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry)
Inhibition of circ_0099999 might have therapeutic benefits in pancreatic cancer.
circ_0099999 is up-regulated in pancreatic cancer tissues and cell lines and functions as an oncogenic circRNA. It promotes proliferation, colony formation, migration, invasion, glycolysis, and xenograft tumour growth while suppressing apoptosis. Mechanistically, cytoplasmic circ_0099999 acts as a ceRNA for miR-330-5p to increase FSCN1 expression, suggesting that circ_0099999 inhibition may have therapeutic value in pancreatic cancer.
0.7859
A novel circ_0099999/miR-330-5p/FSCN1 ceRNA crosstalk in pancreatic cancer.
combined biological and clinical study